Table 2.
ECOG (**) | |||||
---|---|---|---|---|---|
0 | 1 | 2 | Total | ||
CR/PR | 10 (58.8%) | 7 (41.2%) | 0 (0%) | 17 (100%) | |
PD | 8 (18.6%) | 21 (48.8%) | 14 (32.6%) | 43 (100%) | |
Total | 18 (30.0%) | 28 (46.7%) | 14 (23.3%) | 60 (100%) | |
Number of Metastatic Sites (*) | |||||
CR/PR | < 3 | ≥3 | Total | ||
9 (52.9%) | 8 (47.1%) | 17 (100%) | |||
PD | 13 (30.2%) | 30 (69.8%) | 43 (100%) | ||
Total | 22 (36.7%) | 38 (63.3%) | 60 (100%) | ||
Age (*) | |||||
CR/PR | 72 (64–76) | ||||
PD | 64 (54–72) |
* p-value < 0.10; ** p-value < 0.05.